Compile Data Set for Download or QSAR
maximum 50k data
Found 1745 Enz. Inhib. hit(s) with Target = 'Somatostatin receptor type 3'
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50352489(CHEMBL1824052)
Affinity DataEC50:  0.230nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523757(US11136312, Compound MM-I-87)
Affinity DataEC50:  0.249nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523756(US11136312, Compound MM-I-83)
Affinity DataEC50:  0.276nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50352480(CHEMBL1824051)
Affinity DataEC50:  0.350nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(MOUSE)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50021063(CHEMBL3287613)
Affinity DataEC50:  0.460nMAssay Description:Agonist activity at mouse SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154508(CHEMBL3775042)
Affinity DataEC50:  0.460nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50021074(CHEMBL3287628)
Affinity DataEC50:  0.516nMAssay Description:Agonist activity at human SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50352483(CHEMBL1824056)
Affinity DataEC50:  0.530nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523754(US11136312, Compound MM-I-66)
Affinity DataEC50:  0.585nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523801(US11136312, Compound SK-I-128)
Affinity DataEC50:  0.619nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM82547(SRIF-D-Trp8)
Affinity DataEC50:  0.630nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523770(US11136312, Compound SK-I-124)
Affinity DataEC50:  0.725nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM81767(15-28-Somatostatin-28 | CAS_38916-34-6 | CB6417646...)
Affinity DataEC50:  0.780nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50352481(CHEMBL1824050)
Affinity DataEC50:  0.870nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50400517(CHEMBL2204935)
Affinity DataEC50:  0.950nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523803(US11136312, Compound SK-I-132)
Affinity DataEC50:  0.992nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523766(US11136312, Compound SK-I-57)
Affinity DataEC50:  1nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523760(US11136312, Compound SK-I-22)
Affinity DataEC50:  1.28nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50021075(CHEMBL3287629)
Affinity DataEC50:  1.60nMAssay Description:Agonist activity at human SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523759(US11136312, Compound SK-I-16)
Affinity DataEC50:  1.76nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523762(US11136312, Compound SK-I-25)
Affinity DataEC50:  2.03nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50091557(CHEMBL3582317)
Affinity DataEC50:  2.5nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523758(US11136312, Compound MM-I-89)
Affinity DataEC50:  2.80nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50021063(CHEMBL3287613)
Affinity DataEC50:  2.90nMAssay Description:Agonist activity at human SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523802(US11136312, Compound SK-I-130)
Affinity DataEC50:  3.09nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154509(CHEMBL3775387)
Affinity DataEC50:  3.10nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523767(US11136312, Compound SK-I-91)
Affinity DataEC50:  3.17nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154507(CHEMBL3775630)
Affinity DataEC50:  3.30nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523755(US11136312, Compound MM-I-72)
Affinity DataEC50:  3.32nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50136824((4R,7S,10S,13S,16R,19S,22S,25R)-16-((1H-indol-3-yl...)
Affinity DataEC50:  3.33nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50021090(CHEMBL3287632)
Affinity DataEC50:  3.70nMAssay Description:Agonist activity at human SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523742(US11136312, Compound SM-I-50)
Affinity DataEC50:  4.35nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50021073(CHEMBL3287627)
Affinity DataEC50:  4.5nMAssay Description:Agonist activity at human SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50352482(CHEMBL1824055)
Affinity DataEC50:  4.70nMAssay Description:Partial agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154423(CHEMBL3774684)
Affinity DataEC50:  4.80nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50110470(CHEMBL3605798)
Affinity DataEC50:  5.20nMAssay Description:Agonist activity at human SSTR3 expressed in CHO cells assessed as intracellular cAMP level after 45 mins by time-resolved fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154465(CHEMBL3775760)
Affinity DataEC50:  5.5nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523765(US11136312, Compound SK-I-56)
Affinity DataEC50:  5.63nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50400519(CHEMBL2204941)
Affinity DataEC50:  5.70nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523763(US11136312, Compound SK-I-53)
Affinity DataEC50:  5.97nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523764(US11136312, Compound SK-I-55)
Affinity DataEC50:  6.02nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523738(US11136312, Compound BN-VI-97)
Affinity DataEC50:  6.08nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50021064(CHEMBL3287614)
Affinity DataEC50:  6.10nMAssay Description:Agonist activity at human SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154521(CHEMBL3775532)
Affinity DataEC50:  6.40nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523768(US11136312, Compound SK-I-105)
Affinity DataEC50:  6.65nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523734(US11136312, Compound BN-VI-56)
Affinity DataEC50:  7.26nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523761(US11136312, Compound SK-I-23)
Affinity DataEC50:  7.27nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154451(CHEMBL3775061)
Affinity DataEC50:  7.40nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50546560(CHEMBL4778342)
Affinity DataEC50:  7.90nMAssay Description:Agonist activity at human SST3More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50110461(CHEMBL3605789)
Affinity DataEC50:  8.10nMAssay Description:Agonist activity at human SSTR3 expressed in CHO cells assessed as intracellular cAMP level after 45 mins by time-resolved fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 1745 total ) | Next | Last >>
Jump to: